This book, in a new, extensively updated edition, covers viral infection, virus-induced inflammation and tissue injuries, viral epidemiology, oncogenic mechanisms, and current and emerging preventive and therapeutic strategies in detail. Readers will also find information on the individual aspects of a number of oncogenic viruses, including hepatitis B, hepatitis C, human papillomavirus, Epstein-Barr virus, human T-cell lymphotropic virus, Kaposi sarcoma-associated herpes, and Merkel cell polyomavirus, as well as associated human cancers. 

The book will benefit all those who are seeking a comprehensive, up-to-date overview of the basic and clinical aspects of oncogenic viruses and associated human cancers. Following its original publication in 2014, the first edition of this book quickly became an influential text in the field. This second edition duly reflects the significant advances in knowledge and research that have been achieved in the years since. 

Virus infection and human cancer - An overview

Epidemiology of virus infection and human cancer
Viral oncogenes and human cancer
Virus infection, inflammation and cancer prevention
The oncogenic role of hepatitis B virus
Prevention of hepatitis B virus infection and liver cancer
The oncogenic role of hepatitis C virus
Prevention of hepatitis C virus infection and liver cancer
The oncogenic role of Human Papilloma virus
Prevention of Human Papilloma virus and related cancers
The oncogenic role of Epstein-Barr virus
Prevention of Epstein-Barr virus infection and related cancers.- The oncogenic role of Human T-Cell Lymphotropic virus
Prevention of Human T-Cell Lymphotropic virus infection and adult T-Cell leukemia
The oncogenic role of Kaposi sarcoma-associated herpes virus (HHV-8).- Prevention of Kaposi sarcoma-associated herpes virus (HHV-8) and Kaposi's sarcoma.- Merkel cell polyomavirus (MCV) and human Merkel cell carcinoma.- Infection-associated cancer after transplantation - Prevention and cure.- Viral infection and cancer prevention - Future prospects.